Related Experiment Video
Updated: Aug 28, 2025
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Photodynamic therapy of lung cancer, where are we?
Anine Crous1, Heidi Abrahamse1
1Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa.
Abstract:
Lung cancer remains the leading threat of death globally, killing more people than colon, breast, and prostate cancers combined. Novel lung cancer treatments are being researched because of the ineffectiveness of conventional cancer treatments and the failure of remission. Photodynamic therapy (PDT), a cancer treatment method that is still underutilized, is a sophisticated cancer treatment that shows selective destruction of malignant cells via reactive oxygen species production. PDT has been extensively studied in vitro and clinically. Various PDT strategies have been shown to be effective in the treatment of lung cancer. PDT has been shown in clinical trials to considerably enhance the quality of life and survival in individuals with incurable malignancies. Furthermore, PDT, in conjunction with the use of nanoparticles, is currently being researched for use as an effective cancer treatment, with promising results. PDT and the new avenue of nanoPDT, which are novel treatment options for lung cancer with such promising results, should be tested in clinical trials to determine their efficacy and side effects. In this review, we examine the status and future potentials of nanoPDT in lung cancer treatment.
Insights
Photodynamic therapy (PDT) offers a novel approach to treating lung cancer by selectively destroying malignant cells. Combining PDT with nanoparticles (nanoPDT) shows promise for improving patient outcomes and warrants further clinical investigation.
Area of Science:
- Oncology
- Photochemistry
- Nanomedicine
Background:
- Lung cancer is a leading global cause of mortality, with conventional treatments often proving ineffective.
- Photodynamic therapy (PDT) utilizes reactive oxygen species for selective cancer cell destruction.
- PDT has demonstrated efficacy in improving quality of life and survival rates for patients with advanced cancers.
Purpose of the Study:
- To review the current status and future potential of photodynamic therapy (PDT) in lung cancer treatment.
- To explore the emerging role of nanoparticle-mediated photodynamic therapy (nanoPDT) as a novel therapeutic strategy.
- To highlight the need for further clinical trials to evaluate the efficacy and safety of nanoPDT for lung cancer.
Main Methods:
- Review of existing in vitro and clinical studies on photodynamic therapy for lung cancer.
- Analysis of research on nanoparticle-drug delivery systems in conjunction with PDT.
- Examination of clinical trial data regarding PDT's impact on patient survival and quality of life.
Main Results:
- PDT has shown effectiveness in various lung cancer treatment strategies.
- Clinical trials indicate PDT can significantly enhance survival and quality of life in patients with incurable lung cancer.
- Emerging research on nanoPDT suggests promising results for enhanced cancer treatment efficacy.
Conclusions:
- Photodynamic therapy (PDT) represents an underutilized yet effective treatment modality for lung cancer.
- Nanoparticle-enhanced photodynamic therapy (nanoPDT) is a promising novel approach requiring further research.
- Clinical trials are essential to validate the efficacy and safety profile of nanoPDT in lung cancer patients.
